Firefly and Zeto announce partnership

A brilliant read for anyone in the neuro / neuro med tech space. This important study demonstrates the ability of BioEP to reveal likelihood of epilepsy from EEGs that are currently considered clinically uninformative. These exciting findings offer the opportunity for diagnostic decision support tools to augment clinical practice in epilepsy diagnosis…. We are so excited to see the impact BioEP can have on the incredibly difficult process of diagnosis of epilepsy 🧠 #neurology #epilepsy #biomarkerks #SaMD

Reminder: HITLAB is still recruiting participants in 3 different research projects.    They include: ‣ Soliddd Corp – We are seeking retina specialists, low-visions specialists and ophthalmologists for a project aimed at validating a groundbreaking solution that offers real vision correction for macular degeneration (AMD). AMD is a leading cause of irreversible vision loss, affecting about 8.7% of all blind individuals globally. With projections indicating nearly 288 million people will be affected by 2040, your expertise can make a significant difference in combating this global health challenge. https://lnkd.in/eHS5FygV      ‣ VitalTracer Ltd. –HITLAB is working on a groundbreaking research project aimed at revolutionizing vital sign monitoring practices for pediatric oncology patients. Currently, we are looking for: Pediatric Oncologists, Surgeons, and Post-Surgery Pediatric Care Nurses. Learn more here: https://lnkd.in/eHS5FygV    ‣ iFocus Health: HITLAB is working on a project aimed at revolutionizing ADHD Treatments effectiveness through an AI-powered biomarker. We are currently looking for clinicians and psychiatrists who prescribe ADHD medications. Learn more or sign up to participate here: https://lnkd.in/eHS5FygV   

Exciting new research from the Swedish BioFINDER-2 study demonstrates the potential of remote, unsupervised digital memory assessments via mobile devices. 📱🧠 Highlights: ✅ Remote and unsupervised digital memory assessments are feasible in older adults and individuals in early stages of Alzheimer's disease. ✅ Digital memory assessments are associated with neuropsychological in-clinic assessments, tau-positron emission tomography and magnetic resonance imaging measures. ✅ Combination of digital memory assessments with plasma p-tau217 holds promise for prognosis of future cognitive decline. This innovative approach could complement traditional cognitive assessments in clinical and research settings, making it easier to detect and monitor cognitive impairment in Alzheimer's disease. The future of Alzheimer's diagnosis and monitoring is becoming increasingly digital and accessible!

🧠 ⚙ 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡 𝐍𝐨𝐭𝐚𝐛𝐥𝐞𝐬 #𝟐𝟑: 𝐉𝐚𝐧 𝟐𝟎𝟐𝟓 💼 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 & 𝐀𝐠𝐞𝐧𝐜𝐲 𝐔𝐩𝐝𝐚𝐭𝐞𝐬 𝐢𝐧 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡 💼 📄 The FDA has released a draft guidance about AI-enabled device software functions with a compilation of insights from over 1,000 AI-enabled device authorizations. For those interested: A webinar is scheduled for February 18, with comments due by April 7, offering an opportunity for stakeholders to impact future policies. 📝 The Advanced Research Projects Agency for Health (ARPA-H)’s Network Survey will help accelerate med device and diagnostic reimbursement strategies to bridge gaps in bringing devices to market efficiently. Responses due by February 21, 2025. 🔌 The FDA Breakthrough Device Designation was granted for closed-loop transcranial alternating current stimulation to treat major depressive disorder. 📢 Comphya has received the FDA IDE approval to begin U.S. trials for CaverSTIM, the first implantable neuromodulator for erectile dysfunction. 🚀 ONWARD Medical has earned the FDA De Novo classification and a U.S. market authorization for its non-invasive spinal cord stimulation system for chronic spinal cord injury, the first in neurorehabilitation that's accessible. ✅ Medtronic has won the CE mark approval for its adaptive deep brain stimulation technology for Parkinson’s disease. 🎉 Abbott’s Liberta RC™ DBS System has received the CE mark approval, adding next-generation deep brain stimulation to the toolkit for managing neurological conditions. 🔬 ARPA-H has launched the PROSPR program to build on NIA’s work accelerating the development of therapeutics for enhancing healthspan. 📚 The American College of Surgeons released new Traumatic Brain Injury (TBI) care guidelines. 🛡️ The Defense Bill has mandated new military actions on brain injury, a crucial development in neurohealth for service members and veterans. 💰 The U.S. Senate has passed an act tripling funding for state and local dementia programs. 👩⚕️ Director of the FDA CDRH, Dr. Michelle Tarver, has shared their vision for neurotech and device regulation. 🏡 The FDA’s "Home as a Health Care Hub" Idea Lab details how remote monitoring & home-based care models can seamlessly integrate into healthcare ecosystems. 🤔 The GAO has released a report on "BCI: Applications, Challenges, and Policy Options," with insights into ethical, regulatory, and technical considerations of BCIs. #Neurotech #BrainHealth #Neuromodulation #AIinHealthcare #MentalHealthTech #BrainComputerInterface #WearableTech #MedicalDevices #Neuroscience #DigitalHealth

More and more scientific tailwind for Rhyk Technologies. Based on the latest biostimulation technology, more than 10 years of application experience and profound medical and biophysical know-how, we develop #electropharmaceuticals to efficiently support the body in its healing processes❤️🩹. It is only the beginning of a new era of therapies. more to come 💪🚀💪 #biostimulation #healthyaging

🧠 ⚙ 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡 𝐍𝐨𝐭𝐚𝐛𝐥𝐞𝐬 #𝟐𝟐: 𝐃𝐞𝐜 𝟐𝟎𝟐𝟒 💼 𝐌𝐨𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐔𝐩𝐝𝐚𝐭𝐞𝐬 𝐢𝐧 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡! 💼 🧠 SynchNeuro, Inc. just unveiled the first non-invasive, EEG-based continuous glucose monitor, merging neurotech with metabolic monitoring. This can be a potential game-changer for diabetes care. 🌟 📢 Artinis Medical Systems shared several updates from 2024, such as its first CE/MDR medical device approval and a strategic acquisition. 🚀 🎓 WAT Medical Enterprise is sponsoring the American Headache Society 2024 Scottsdale Headache Symposium. 💡 📑 LivaNova is poised to present new scientific data on epilepsy-focused neuromodulation research at the American Epilepsy Society 2024 Annual Meeting. 🔬 🏢 A new neuroscience center supporting brain research and innovation is coming to The Rockefeller University. 🌍 🧩 Myelin-H introduced "The New Gym For The Brain" to promote cognitive fitness and brain health optimization through neurostimulation and mental exercises. 🏋️♂️ 🔗 rTMS, as highlighted by LSI, is at the forefront of neuromodulation with its non-invasive treatment approach for depression, PTSD, and more. 📈 📊 Experimental Neurology has emphasized a need to enhance data standards in spinal cord injury research to improve translation from research studies to clinical application. 🩺 🕵️♀️ The Milken Institute is working to improve early detection of cognitive impairment and dementia. 🌱 💻 Undeterred Capital has released Research Report 6 on harnessing digital twins in healthcare, demonstrating potential in simulation technology for personalizable healthcare. 💡 📋 Clinical trials for China’s BCI surgeries are set to enroll 30–50 patients in 2025. 🇨🇳 🏆 Definitive Healthcare has named the Top 10 hospitals for epilepsy & seizure diagnoses were listed by Definitive as leading centers of excellence in neurological care. 🧠 🌟 The Foresight Institute’s Vision Weekend showcased emerging neurotech insights and ideas for the future. 🚀 #Neurotechnology #Neuroscience #Neuromodulation #BrainHealth #BCI #Neurotech #MedicalDevices #DigitalHealth #Innovation #HealthTech

🎉 Exciting news from our client, AELIS FARMA! Their recent Phase 1/2 clinical trial for 𝗔𝗘𝗙𝟬𝟮𝟭𝟳 in young adults with Down syndrome has achieved groundbreaking results, showing improvements in communication, daily living skills, and social interactions—key behavioral domains measured by the Vineland Adaptive Behavior Scale (VABS). We are proud to have contributed to this milestone by providing the 𝗘𝗘𝗚 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 that helped uncover critical insights into how AEF0217 impacts brain activity. Using EEG, the study demonstrated 𝘀𝘁𝗮𝘁𝗶𝘀𝘁𝗶𝗰𝗮𝗹𝗹𝘆 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗰𝗵𝗮𝗻𝗴𝗲𝘀 𝗶𝗻 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗲𝗻𝗱𝗽𝗼𝗶𝗻𝘁𝘀, revealing a decrease in the strain required to perform a working memory task and validating the drug's 𝘁𝗮𝗿𝗴𝗲𝘁 𝗲𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁. This achievement underscores the vital role of EEG as acquired with @Neuroelectrics devices in clinical trials to monitor cognition and 𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗰𝗵𝗮𝗻𝗴𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗯𝗿𝗮𝗶𝗻. As AELIS Farma’s success demonstrates, EEG is a powerful tool not only for validating therapeutic efficacy but also for deepening our understanding of how novel treatments influence the brain's function. 👏 We extend our congratulations to AELIS FARMA, the clinical teams led by Prof. Rafael de la Torre Fornell (Barcelona) and Dr. Diego Real de Asúa (Madrid), and especially to the participants and their families for their trust and collaboration. 💡 At Starlab, we facilitate the integration of EEG into clinical trials as an essential measure of cognitive and neurophysiological impact. If you're interested in leveraging EEG for your clinical trials, feel free to reach out—we’re here to help you unlock new insights! #EEG #ClinicalTrials #DownSyndrome #Innovation #Cognition #Neurotechnology #Pharma Neuroelectrics

🧠 ⚙ 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡 𝐍𝐨𝐭𝐚𝐛𝐥𝐞𝐬 #𝟏𝟖: 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟎𝟐𝟒 💡 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐍𝐞𝐰𝐬 𝐢𝐧 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡! 💡 🔬 CALYX and Invicro recently rebranded as Perceptive Inc., a strategic move better aligning with their expanded capabilities in imaging & data solutions. 📊 🧠 Rune Labs’ StrivePD program, partnering with Kaiser Permanente, has demonstrated impressive results reducing ER visits for Parkinson’s patients by approximately 50%. 🚀 📅 At the Congress of Neurological Surgeons Annual Meeting, the Rockefeller Neuroscience Institute and Penn Medicine, University of Pennsylvania Health System shared neural implant data, highlighting Precision Neuroscience’s advancements in BCI technology. 🌟 🔍 Sonera introduced magnetic sensing technology for human-computer interaction. 📡 🏥 FUSMobile’s NeurolyserXR started clinical trials for sacroiliac joint pain, offering a non-invasive alternative for pain management. 🔗 🧠 Brainbox Ltd is enhancing ALS research through use of its DuoMAG MP Dual TMS System. 💡 👥 Synaptrix Labs wins first place at the NYU Entrepreneurs Festival. 🏆 💼 Tivic Health’s vagus nerve stimulation approach received IRB approval from The Feinstein Institutes, a milestone in enhancing non-invasive neurotherapies. 🧠 🚀 CogniScreen announces its entry into Startup Health Alzheimer’s Moonshot, advancing digital cognitive assessments for Alzheimer’s disease. 🌍 🧠 Helius Medical Technologies, Inc. shared promising preliminary results from the PoNSTEP study, enhancing neuromodulation technology for patients with multiple sclerosis and balance issues. 🏥 #Neurotech #BrainHealth #HealthTech #Neuromodulation #AIinHealthcare #Innovation #MedTech #HealthcareInnovation #BrainMachineInterface #Neuroengineering

Compumedics Limited - Official Executive Chairman & CEO David Burton was interviewed on ausbiz by Andrew Geoghegan, highlighting the Company's milestone in securing its largest contract by installing an advanced imaging system at a Chinese university. This $14 million order is part of the Orion system commercialisation, showcasing Compumedics' focus on expanding its market presence. David explains the Magnetoencephalography system as a brain optimised scanner designed for diagnosing brain functional disorders like Alzheimer's and epilepsy. The Orion Lifespan scanner efficiently caters to both children and adults, reflecting innovation in addressing brain health. Looking ahead, David mentions a strong contract pipeline with $14 million in orders and several potential deals in progress. The innovation in brain scanning technology presents vast opportunities, especially with the growing demand for accurate diagnoses in ageing populations globally. Watch the full interview here: https://lnkd.in/gGsR5av2 #sleep #medtech #smallcaps

🌟 Excited to Share My Latest Research! 🌟 I’m pleased to announce that I, along with my fellow researcher Jahangir R., have published our article, "Leveraging CapsNet for Enhanced Classification of 3D MRI Images for Alzheimer’s Diagnosis," has been published in Biomedical Signal Processing and Control. This research presents a Hybrid CapsNet-3D model designed to improve early-stage Alzheimer’s Disease (AD) diagnosis. By combining Capsule Networks with 3D convolutional layers and leveraging hippocampal volume measurement through the ASHS approach, this framework enhances feature retention and preserves critical 3D MRI details for better diagnostic precision. I believe this work contributes to advancing AI’s role in healthcare and neuroimaging, offering new possibilities for early AD detection. 🔗 Read the full article here: https://lnkd.in/emseVf9c I’m eager to hear your feedback or ideas on this work. Let’s continue the conversation about advancing healthcare innovation! #ResearchPublication #AIinHealthcare #AlzheimersResearch #CapsuleNetworks #BiomedicalInnovation